Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

2055results about "Handling using diaphragms/collimeters" patented technology

Illumination system particularly for microlithography

The invention concerns an illumination system, particularly for microlithography with wavelengths <=193 nm, comprising a light source, a first optical component, a second optical component, an image plane and an exit pupil. The first optical component transforms the light source into a plurality of secondary light sources being imaged by the second optical component in said exit pupil. The first optical component comprises a first optical element having a plurality of first raster elements, which are imaged into said image plane producing a plurality of images being superimposed at least partially on a field in said image plane. The first raster elements deflect incoming ray bundles with first deflection angles, wherein at least two of the first deflection angles are different. The first raster elements are preferably rectangular, wherein the field is a segment of an annulus. To transform the rectangular images of the first raster elements into the segment of the annulus, the second optical component comprises a first field mirror for shaping the field to the segment of the annulus.
Owner:CARL-ZEISS-STIFTUNG TRADING AS CARL ZEISS

Method and a device for maintaining the performance quality of a code-division multiple access system in the presence of narrow band interference

A method and device which dynamically detects, tracks and filters interfering signals with sufficient speed (i.e. within one IS-95 CDMA data frame period, or 20ms and fidelity to eliminate or greatly reduce the deleterious effects of narrow band interferor signals on a CDMA link. When inserted in an RF signal path an Adaptive Notch Filter (ANF) detects narrow band interferors above a threshold level within the CDMA signal. Detection is accomplished by continuous scanning of a preset excision band, e.g. a specified narrow band associated with an AMPS system. Detected interferors are then automatically acquired and suppressed. This is achieved by electronically placing a rejection notch at the frequency of the interferors. Multiple notch filters may be used to simultaneously suppress multiple interferors. In the absence of interferors a bypass mode is selected allowing the RF signal to bypass the notch. Upon detection of an interferor, a switch is made to a suppression mode where the interferor is steered through a first notch section and suppressed. Alternatively, an external control line may be used to select the bypass mode so that the signal is allowed to pass the notch section, regardless of interferer content.
Owner:ILLINOIS SUPER CONDUCTOR CANADA CORP A CO INC UNDER THE LAWS OF CANADA +1

Orthovoltage radiotherapy

ActiveUS20080212738A1Dry up neovascular membraneStabilized and improved acuityHandling using diaphragms/collimetersRadiation beam directing meansRadiosurgeryBeam energy
A radiosurgery system is described that is configured to deliver a therapeutic dose of radiation to a target structure in a patient. In some embodiments, inflammatory ocular disorders are treated, specifically macular degeneration. In some embodiments, other disorders or tissues of a body are treated with the dose of radiation. In some embodiments, the target tissues are placed in a global coordinate system based on ocular imaging. In some embodiments, the target tissues inside the global coordinate system lead to direction of an automated positioning system that is directed based on the target tissues within the coordinate system. In some embodiments, a treatment plan is utilized in which beam energy and direction and duration of time for treatment is determined for a specific disease to be treated and / or structures to be avoided. In some embodiments, a fiducial marker is used to identify the location of the target tissues. In some embodiments, radiodynamic therapy is described in which radiosurgery is used in combination with other treatments and can be delivered concomitant with, prior to, or following other treatments.
Owner:CARL ZEISS MEDITEC INC

X-ray protection device

A shielding arrangement for an x-ray apparatus, preferably for mammography examination is disclosed, and comprises at least an x-ray source, a collimator arrangement and a detector assembly, whereby the collimator is arranged between the x-ray source and the detector assembly and through which x-rays pass. The shielding arrangement, at least partly made of x-ray blocking material and provided for blocking, scattering and / or reflecting x-rays is arranged, at least partly, in a space between the x-ray source and collimator.
Owner:PHILIPS DIGITAL MAMMOGRAPHY SWEDEN

Method and apparatus for imaging with imaging detectors having small fields of view

An apparatus for imaging a structure of interest comprises a plurality of imaging detectors mounted on a gantry. Each of the plurality of imaging detectors has a field of view (FOV), is independently movable with respect to each other, and is positioned to image a structure of interest within a patient. A data acquisition system receives image data detected within the FOV of each of the plurality of imaging detectors.
Owner:GE HEALTHCARE ISRAEL

Focusable and steerable micro-miniature x-ray apparatus

A micro-miniature x-ray apparatus comprises: a first chip subassembly including a source of x-rays including both Bremsstrahlung photons and characteristic x-rays; a second chip subassembly including a filter for transmitting the characteristic x-rays and blocking the Bremsstrahlung photons; a third chip subassembly including a movable element for focusing or collimating the transmitted characteristic x-rays into a beam and means for controlling the position of the focusing element. In one embodiment, the controlling means include a micro-electromechanical system (MEMS). In another embodiment, the position of the movable element determines how the x-ray beam is steered to the focal area. In still another embodiment, the x-ray source includes a field emitter electron source and a target responsive to the electrons for generating x-rays. In this case, the x-ray beam is also steered by selectively energizing the anode segments. In yet another embodiment, the movable element includes a Fresnel zone plate; in still another embodiment it includes an array of poly-capillaries. Advantageously, our x-ray source, including its focusing, collimating and steering components, can be fabricated small enough to be mounted at the end of a catheter. In addition, in some embodiments it can also fabricated sufficiently inexpensively to be disposable after each use.
Owner:LUCENT TECH INC

Cardiovascular imaging and functional analysis system

A cardiovascular imaging and functional analysis system and method is disclosed, wherein a dedicated fast, sensitive, compact and economical imaging gamma camera system that is especially suited for heart imaging and functional analysis is employed. The cardiovascular imaging and functional analysis system of the present invention can be used as a dedicated nuclear cardiology small field of view imaging camera. The disclosed cardiovascular imaging system and method has the advantages of being able to image physiology, while offering an inexpensive and portable hardware, unlike MRI, CT, and echocardiography systems.The cardiovascular imaging system of the invention employs a basic modular design suitable for cardiac imaging with one of several radionucleide tracers. The detector can be positioned in close proximity to the chest and heart from several different projections, making it possible rapidly to accumulate data for first-pass analysis, positron imaging, quantitative stress perfusion, and multi-gated equilibrium pooled blood (MUGA) tests..In a preferred embodiment, the Cardiovascular Non-Invasive Screening Probe system can perform a novel diagnostic screening test for potential victims of coronary artery disease. The system provides a rapid, inexpensive preliminary indication of coronary occlusive disease by measuring the activity of emitted particles from an injected bolus of radioactive tracer. Ratios of this activity with the time progression of the injected bolus of radioactive tracer are used to perform diagnosis of the coronary patency (artery disease).
Owner:NORTH COAST IND INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products